Search

Michael D. Pak

Examiner (ID: 12379, Phone: (571)272-0879 , Office: P/1646 )

Most Active Art Unit
1646
Art Unit(s)
1812, 0, 1674, 1646, 1621
Total Applications
1549
Issued Applications
720
Pending Applications
264
Abandoned Applications
571

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11382908 [patent_doc_number] => 20170008964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'ANTIBODY DRUG CONJUGATES' [patent_app_type] => utility [patent_app_number] => 15/204210 [patent_app_country] => US [patent_app_date] => 2016-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 54735 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15204210 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/204210
ANTIBODY DRUG CONJUGATES Jul 6, 2016 Abandoned
Array ( [id] => 11106130 [patent_doc_number] => 20160303100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'Brown Adipocyte Progenitors in Human Skeletal Muscle' [patent_app_type] => utility [patent_app_number] => 15/198361 [patent_app_country] => US [patent_app_date] => 2016-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11102 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15198361 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/198361
Brown Adipocyte Progenitors in Human Skeletal Muscle Jun 29, 2016 Abandoned
Array ( [id] => 19273260 [patent_doc_number] => 12023367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Immunomodulation for the long term prevention and treatment of autoimmune diseases and foreign tissue rejection [patent_app_type] => utility [patent_app_number] => 15/736088 [patent_app_country] => US [patent_app_date] => 2016-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 28 [patent_no_of_words] => 15363 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736088 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/736088
Immunomodulation for the long term prevention and treatment of autoimmune diseases and foreign tissue rejection Jun 16, 2016 Issued
Array ( [id] => 13338227 [patent_doc_number] => 20180220653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => Methods for Identifying Compounds that Directly Bind to Insect Transient Receptor Potential Channels [patent_app_type] => utility [patent_app_number] => 15/737170 [patent_app_country] => US [patent_app_date] => 2016-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26065 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737170 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/737170
Methods for Identifying Compounds that Directly Bind to Insect Transient Receptor Potential Channels Jun 16, 2016 Abandoned
Array ( [id] => 14390895 [patent_doc_number] => 10308717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-04 [patent_title] => Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor [patent_app_type] => utility [patent_app_number] => 15/182775 [patent_app_country] => US [patent_app_date] => 2016-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 29 [patent_no_of_words] => 51637 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15182775 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/182775
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor Jun 14, 2016 Issued
Array ( [id] => 18779114 [patent_doc_number] => 11820807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-21 [patent_title] => Immunoglobulin fusion proteins and uses thereof [patent_app_type] => utility [patent_app_number] => 15/177605 [patent_app_country] => US [patent_app_date] => 2016-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 23 [patent_no_of_words] => 17143 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15177605 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/177605
Immunoglobulin fusion proteins and uses thereof Jun 8, 2016 Issued
Array ( [id] => 11401745 [patent_doc_number] => 20170022281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'PROLACTIN RECEPTOR BINDING PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/176137 [patent_app_country] => US [patent_app_date] => 2016-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 75712 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15176137 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/176137
Prolactin receptor binding proteins and uses thereof Jun 6, 2016 Issued
Array ( [id] => 18444684 [patent_doc_number] => 11680244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-20 [patent_title] => Method for generating human dendritic cells for immunotherapy [patent_app_type] => utility [patent_app_number] => 15/575073 [patent_app_country] => US [patent_app_date] => 2016-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 10457 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575073 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/575073
Method for generating human dendritic cells for immunotherapy May 18, 2016 Issued
Array ( [id] => 14485175 [patent_doc_number] => 10329355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-25 [patent_title] => Compositions and methods for targeting stromal cells for the treatment of cancer [patent_app_type] => utility [patent_app_number] => 15/158727 [patent_app_country] => US [patent_app_date] => 2016-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 36000 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158727 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/158727
Compositions and methods for targeting stromal cells for the treatment of cancer May 18, 2016 Issued
Array ( [id] => 14456277 [patent_doc_number] => 10324095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Methods for diagnosing osteoarthritis [patent_app_type] => utility [patent_app_number] => 15/158689 [patent_app_country] => US [patent_app_date] => 2016-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 40 [patent_no_of_words] => 18792 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158689 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/158689
Methods for diagnosing osteoarthritis May 18, 2016 Issued
Array ( [id] => 11491382 [patent_doc_number] => 20170065568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'METHODS AND COMPOUNDS FOR CALCIUM ION CHANNEL REGULATION' [patent_app_type] => utility [patent_app_number] => 15/154140 [patent_app_country] => US [patent_app_date] => 2016-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7067 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15154140 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/154140
METHODS AND COMPOUNDS FOR CALCIUM ION CHANNEL REGULATION May 12, 2016 Abandoned
Array ( [id] => 11107632 [patent_doc_number] => 20160304603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'METHODS FOR MODULATING MANNOSE CONTENT OF RECOMBINANT PROTEINS' [patent_app_type] => utility [patent_app_number] => 15/150627 [patent_app_country] => US [patent_app_date] => 2016-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16595 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15150627 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/150627
Methods for modulating mannose content of recombinant proteins May 9, 2016 Issued
Array ( [id] => 11123427 [patent_doc_number] => 20160320401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'METHOD AND APPARATUS FOR SIGNAL TRANSDUCTION PATHWAY PROFILING' [patent_app_type] => utility [patent_app_number] => 15/149843 [patent_app_country] => US [patent_app_date] => 2016-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7213 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15149843 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/149843
METHOD AND APPARATUS FOR SIGNAL TRANSDUCTION PATHWAY PROFILING May 8, 2016 Abandoned
Array ( [id] => 11123440 [patent_doc_number] => 20160320414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'Assay for Detection of Transient Intracellular CA2+' [patent_app_type] => utility [patent_app_number] => 15/147326 [patent_app_country] => US [patent_app_date] => 2016-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 7144 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15147326 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/147326
Assay for Detection of Transient Intracellular CA2+ May 4, 2016 Abandoned
Array ( [id] => 18154098 [patent_doc_number] => 11567073 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-31 [patent_title] => Receptor tyrosine kinase biomarkers [patent_app_type] => utility [patent_app_number] => 15/569871 [patent_app_country] => US [patent_app_date] => 2016-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 4 [patent_no_of_words] => 12776 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569871 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/569871
Receptor tyrosine kinase biomarkers Apr 27, 2016 Issued
Array ( [id] => 13590063 [patent_doc_number] => 20180346580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => Antibodies to Canine Interleukin-4 Receptor Alpha [patent_app_type] => utility [patent_app_number] => 15/562308 [patent_app_country] => US [patent_app_date] => 2016-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31991 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562308 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/562308
Antibodies to canine interleukin-4 receptor alpha Mar 31, 2016 Issued
Array ( [id] => 13593365 [patent_doc_number] => 20180348231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => LIGAND INDUCIBLE POLYPEPTIDE COUPLER SYSTEM [patent_app_type] => utility [patent_app_number] => 15/562290 [patent_app_country] => US [patent_app_date] => 2016-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30372 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562290 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/562290
LIGAND INDUCIBLE POLYPEPTIDE COUPLER SYSTEM Mar 28, 2016 Abandoned
Array ( [id] => 13548781 [patent_doc_number] => 20180325938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => METHOD OF EVALUATING OR SELECTING ANDROGEN RECEPTOR ACTIVITY REGULATOR SELECTIVE TO SEBACEOUS GLANDS OR HAIR FOLLICLES [patent_app_type] => utility [patent_app_number] => 15/531636 [patent_app_country] => US [patent_app_date] => 2016-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11290 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15531636 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/531636
METHOD OF EVALUATING OR SELECTING ANDROGEN RECEPTOR ACTIVITY REGULATOR SELECTIVE TO SEBACEOUS GLANDS OR HAIR FOLLICLES Mar 24, 2016 Abandoned
15/068412 RANDOM CONJUGATE MOLECULE AND METHODS OF MAKING AND USING THE SAME Mar 10, 2016 Abandoned
Array ( [id] => 17526859 [patent_doc_number] => 11299531 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-12 [patent_title] => Fusion protein comprising a ligand binding domain of VEGF and PDGF [patent_app_type] => utility [patent_app_number] => 15/542692 [patent_app_country] => US [patent_app_date] => 2016-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 14848 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542692 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/542692
Fusion protein comprising a ligand binding domain of VEGF and PDGF Mar 9, 2016 Issued
Menu